The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blease, K.
Right arrow Articles by Hogaboam, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blease, K.
Right arrow Articles by Hogaboam, C. M.
The Journal of Immunology, 2001, 167: 6583-6592.
Copyright © 2001 by The American Association of Immunologists

IL-13 Fusion Cytotoxin Ameliorates Chronic Fungal-Induced Allergic Airway Disease in Mice1

Kate Blease*, Claudia Jakubzick*, Jane M. Schuh*, Bharat H. Joshi{dagger}, Raj K. Puri{dagger} and Cory M. Hogaboam2,*

* Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; and {dagger} Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892

IL-13 has emerged as a major contributor to allergic and asthmatic responses, and as such it represents an attractive target in these diseases. In this study, IL-13-responsive cells in the lung were targeted via the intranasal administration of IL-13-PE38QQR (IL-13-PE), comprised of human IL-13 and a derivative of Pseudomonas exotoxin, to Aspergillus fumigatus-sensitized mice challenged with A. fumigatus spores, or conidia. Mice received 50, 100, or 200 ng of IL-13-PE or diluent alone (i.e., control group) on alternate days from day 14 to day 28 after the conidia challenge. The control group of mice exhibited significant airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis at day 28 after conidia. Although the two lower doses of IL-13-PE had limited therapeutic effects in mice with fungal-induced allergic airway disease, the highest dose of IL-13-PE tested significantly reduced all features of airway disease compared with the control group. Whole lung mRNA expression of IL-4R{alpha} and IL-13R{alpha}1 was markedly reduced, whereas bronchoalveolar lavage and whole lung levels of IFN-{gamma} were significantly elevated in mice treated with 200 ng of IL-13-PE compared with the control group. This study demonstrates that a therapy designed to target IL-13-responsive cells in the lung ameliorates established fungal-induced allergic airway disease in mice.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
H. Ramaprakash, T. Ito, T. J. Standiford, S. L. Kunkel, and C. M. Hogaboam
Toll-Like Receptor 9 Modulates Immune Responses to Aspergillus fumigatus Conidia in Immunodeficient and Allergic Mice
Infect. Immun., January 1, 2009; 77(1): 108 - 119.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Shimamura, T. Fujisawa, S. R. Husain, M. Kioi, A. Nakajima, and R. K. Puri
Novel Role of IL-13 in Fibrosis Induced by Nonalcoholic Steatohepatitis and Its Amelioration by IL-13R-Directed Cytotoxin in a Rat Model
J. Immunol., October 1, 2008; 181(7): 4656 - 4665.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Arora, R. A. McDonald, G. B. Toews, and G. B. Huffnagle
Effect of a CD4-Depleting Antibody on the Development of Cryptococcus neoformans-Induced Allergic Bronchopulmonary Mycosis in Mice
Infect. Immun., July 1, 2006; 74(7): 4339 - 4348.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. W. Denning, B. R. O'Driscoll, C. M. Hogaboam, P. Bowyer, and R. M. Niven
The link between fungi and severe asthma: a summary of the evidence.
Eur. Respir. J., March 1, 2006; 27(3): 615 - 626.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Rivera, H. L. Van Epps, T. M. Hohl, G. Rizzuto, and E. G. Pamer
Distinct CD4+-T-Cell Responses to Live and Heat-Inactivated Aspergillus fumigatus Conidia
Infect. Immun., November 1, 2005; 73(11): 7170 - 7179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Jenkins, A. Swiatoniowski, A. C. Issekutz, and T.-J. Lin
Pseudomonas aeruginosa Exotoxin A Induces Human Mast Cell Apoptosis by a Caspase-8 and -3-dependent Mechanism
J. Biol. Chem., August 27, 2004; 279(35): 37201 - 37207.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Jakubzick, E. S. Choi, K. J. Carpenter, S. L. Kunkel, H. Evanoff, F. J. Martinez, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis, et al.
Human Pulmonary Fibroblasts Exhibit Altered Interleukin-4 and Interleukin-13 Receptor Subunit Expression in Idiopathic Interstitial Pneumonia
Am. J. Pathol., June 1, 2004; 164(6): 1989 - 2001.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C Jakubzick, E S Choi, S L Kunkel, H Evanoff, F J Martinez, R K Puri, K R Flaherty, G B Toews, T V Colby, E A Kazerooni, et al.
Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia
J. Clin. Pathol., May 1, 2004; 57(5): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al.
Idiopathic Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. Jakubzick, E. S. Choi, B. H. Joshi, M. P. Keane, S. L. Kunkel, R. K. Puri, and C. M. Hogaboam
Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells
J. Immunol., September 1, 2003; 171(5): 2684 - 2693.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Jakubzick, E. S. Choi, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam
Impact of Interleukin-13 Responsiveness on the Synthetic and Proliferative Properties of Th1- and Th2-Type Pulmonary Granuloma Fibroblasts
Am. J. Pathol., May 1, 2003; 162(5): 1475 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Inman
Do Complex Conditions Require Complex Treatment?
Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 6 - 6.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Jakubzick, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam
Interleukin-13 Fusion Cytotoxin Arrests Schistosoma mansoni Egg-Induced Pulmonary Granuloma Formation in Mice
Am. J. Pathol., October 1, 2002; 161(4): 1283 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. M. Schuh, K. Blease, S. L. Kunkel, and C. M. Hogaboam
Eotaxin/CCL11 is involved in acute, but not chronic, allergic airway responses to Aspergillus fumigatus
Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L198 - L204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Schuh, K. Blease, and C. M. Hogaboam
CXCR2 Is Necessary for the Development and Persistence of Chronic Fungal Asthma in Mice
J. Immunol., February 1, 2002; 168(3): 1447 - 1456.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.